The future of dermatology requires an innovative, evidence-based, end-to-end, fully secure solution that improves service delivery, patient outcomes in a cost-effective manner. That’s what we deliver.

How It Works: Simple Five-Step Process

Our fully integrated dermatological service allows front-line healthcare providers to seamlessly consult with dermatologists to offer more effective and efficient patient care.

Gettyimages 1042132642 2048x2048

1. Suspicious Mole Detected

A patient or healthcare provider identifies a pigmented lesion that should be assessed by a dermatologist.

That’s where we come in.

White machine

2. High-Quality Image Capture by Front-Line Healthcare Providers

Our SIAscope is a hand-held Class IIA medical device and the only image-capture technology on the market that provides clinical, dermascopic and spectrophotometric views of moles up to 2 mm below the skin’s surface. Our technology allows healthcare providers, like physicians, pharmacists and healthcare technicians, to capture perfect clinical images with 100% image integrity. Currently approximately 40% of images sent using existing teledermatology platforms cannot be successfully assessed by a dermatologist because of poor image quality. MedX’s advanced imaging technology solves this major issue facing dermatologists wanting to adopt teledermatology in their practice.

7

3. Secure, Rapid Assessment Platform

SIAscopy on DermSecure™ is our secure, cloud-based telemedicine platform and patient management system — it captures the dermatological images from the SIAscope and forwards them for assessment by a dermatologist. These high-quality images, coupled with a patient management work flow specifically designed for dermatological e-consults, provides a rapid assessment platform for clinicians to ensure patients with suspicious pigmented lesions can be assessed swiftly by a dermatologist and the most urgent cases are given expedited treatment.

Remote Dermatologist

4. Dermatologist Assessment

A dermatologist assesses the patient’s suspicious mole or lesion within two business days. The quality of the images facilitates an accurate assessment.

I Stock 689956326

5. Patient Results

Healthcare providers and patients receive secure access to detailed assessment reports and next steps. MedX stores patient’s information for 10 years, which means a patient can retrieve their patient file and take another scan of the same mole or lesion years later and compare it to previous images to see if there has been any change. MedX is the only company in the world that has made this commitment to the patient and their providers.

MedX is committed to information security. Our privacy policies are compliant with global privacy regulations such as:

  • Personal Information Protection & Electronic Documents Act (PIPEDA)
  • Health Insurance Portability and Accountability Act (HIPAA)
  • General Data Protection Regulation (GDPR)

We deploy the latest in security measures, engage in rigorous third-party threat testing and real-time monitoring.

What makes us different?

What you see. The only dermatology device with standardized, fixed focal length clinical, dermascopic, spectrophotometric views of a suspicious mole or lesion.

It will change how you work.
Seamless integration with EMR platforms allows for a more effective, efficient, and collaborative workflow, resulting in improved patient outcomes.

The professional choice.
We design, develop and test in collaboration with dermatologists and primary healthcare providers. We have regulatory approvals in 35 countries including USA, Canada, Australia, Brazil, and the EU.

Cybersecurity assurance.
Our commitment to security and safety is top priority.

Research and innovation are our best hopes against skin cancer and other conditions.

See our Research Papers